Market Closed -
Japan Exchange
02:00:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
6,545
JPY
|
-0.06%
|
|
+7.47%
|
-7.19%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,779,297
|
2,272,316
|
2,126,926
|
1,625,529
|
2,152,106
|
1,878,292
|
-
|
-
|
Enterprise Value (EV)
1 |
1,624,218
|
2,106,456
|
1,967,812
|
1,410,789
|
2,010,861
|
1,705,955
|
1,694,503
|
1,672,842
|
P/E ratio
|
28.1
x
|
18.7
x
|
50.5
x
|
33.9
x
|
38.8
x
|
46
x
|
37.8
x
|
25.8
x
|
Yield
|
2.41%
|
2.02%
|
2.16%
|
2.82%
|
2.13%
|
2.48%
|
2.54%
|
2.67%
|
Capitalization / Revenue
|
2.77
x
|
3.27
x
|
3.29
x
|
2.15
x
|
2.89
x
|
2.55
x
|
2.41
x
|
2.18
x
|
EV / Revenue
|
2.53
x
|
3.03
x
|
3.05
x
|
1.87
x
|
2.7
x
|
2.32
x
|
2.18
x
|
1.94
x
|
EV / EBITDA
|
14.4
x
|
13.2
x
|
22.3
x
|
15.3
x
|
25.1
x
|
19.1
x
|
17.9
x
|
14.3
x
|
EV / FCF
|
19
x
|
28
x
|
36
x
|
15.9
x
|
96
x
|
24
x
|
38.8
x
|
30.1
x
|
FCF Yield
|
5.27%
|
3.57%
|
2.78%
|
6.29%
|
1.04%
|
4.17%
|
2.58%
|
3.32%
|
Price to Book
|
2.83
x
|
3.35
x
|
3.02
x
|
2.17
x
|
2.69
x
|
2.35
x
|
2.32
x
|
2.24
x
|
Nbr of stocks (in thousands)
|
286,383
|
286,511
|
286,686
|
286,689
|
286,795
|
286,806
|
-
|
-
|
Reference price
2 |
6,213
|
7,931
|
7,419
|
5,670
|
7,504
|
6,549
|
6,549
|
6,549
|
Announcement Date
|
5/13/19
|
5/13/20
|
5/12/21
|
5/13/22
|
5/15/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
642,834
|
695,621
|
645,942
|
756,200
|
744,400
|
735,408
|
777,980
|
863,379
|
EBITDA
1 |
112,995
|
159,202
|
88,065
|
92,100
|
80,000
|
89,287
|
94,423
|
117,163
|
EBIT
1 |
86,154
|
125,502
|
51,766
|
53,700
|
40,000
|
49,586
|
61,749
|
92,079
|
Operating Margin
|
13.4%
|
18.04%
|
8.01%
|
7.1%
|
5.37%
|
6.74%
|
7.94%
|
10.66%
|
Earnings before Tax (EBT)
1 |
89,454
|
128,063
|
52,551
|
54,500
|
45,000
|
55,509
|
69,514
|
100,234
|
Net income
1 |
63,386
|
121,767
|
42,119
|
48,000
|
55,400
|
41,043
|
49,922
|
72,993
|
Net margin
|
9.86%
|
17.5%
|
6.52%
|
6.35%
|
7.44%
|
5.58%
|
6.42%
|
8.45%
|
EPS
2 |
221.3
|
425.0
|
147.0
|
167.3
|
193.3
|
142.4
|
173.2
|
253.5
|
Free Cash Flow
1 |
85,546
|
75,157
|
54,705
|
88,742
|
20,951
|
71,120
|
43,700
|
55,578
|
FCF margin
|
13.31%
|
10.8%
|
8.47%
|
11.74%
|
2.81%
|
9.67%
|
5.62%
|
6.44%
|
FCF Conversion (EBITDA)
|
75.71%
|
47.21%
|
62.12%
|
96.35%
|
26.19%
|
79.65%
|
46.28%
|
47.44%
|
FCF Conversion (Net income)
|
134.96%
|
61.72%
|
129.88%
|
184.88%
|
37.82%
|
173.28%
|
87.54%
|
76.14%
|
Dividend per Share
2 |
150.0
|
160.0
|
160.0
|
160.0
|
160.0
|
162.1
|
166.1
|
174.6
|
Announcement Date
|
5/13/19
|
5/13/20
|
5/12/21
|
5/13/22
|
5/15/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2026 S1
|
---|
Net sales
1 |
299,300
|
396,356
|
317,044
|
163,458
|
362,352
|
203,000
|
190,900
|
-
|
184,262
|
174,364
|
358,626
|
187,600
|
198,200
|
196,935
|
176,618
|
373,553
|
177,702
|
187,622
|
182,000
|
-
|
368,000
|
-
|
-
|
440,000
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
16,002
|
23,411
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
32,000
|
97,920
|
34,079
|
5,499
|
60,906
|
13,600
|
-20,600
|
-
|
7,434
|
-2,181
|
5,253
|
8,600
|
26,200
|
26,027
|
5,400
|
31,427
|
6,110
|
12,459
|
3,000
|
-
|
7,500
|
-
|
-
|
44,000
|
Operating Margin
|
10.69%
|
24.71%
|
10.75%
|
3.36%
|
16.81%
|
6.7%
|
-10.79%
|
-
|
4.03%
|
-1.25%
|
1.46%
|
4.58%
|
13.22%
|
13.22%
|
3.06%
|
8.41%
|
3.44%
|
6.64%
|
1.65%
|
-
|
2.04%
|
-
|
-
|
10%
|
Earnings before Tax (EBT)
1 |
33,800
|
94,313
|
34,432
|
5,564
|
61,347
|
13,900
|
-20,600
|
-
|
9,722
|
-1,588
|
8,134
|
9,500
|
27,400
|
28,285
|
7,373
|
35,658
|
8,032
|
10,255
|
4,100
|
-
|
9,500
|
-
|
-
|
46,000
|
Net income
1 |
27,000
|
94,767
|
25,797
|
4,025
|
46,186
|
14,200
|
-12,200
|
-
|
26,897
|
3,568
|
30,465
|
8,600
|
16,300
|
20,339
|
2,790
|
23,129
|
5,969
|
12,722
|
2,700
|
-
|
6,300
|
-
|
-
|
33,700
|
Net margin
|
9.02%
|
23.91%
|
8.14%
|
2.46%
|
12.75%
|
7%
|
-6.39%
|
-
|
14.6%
|
2.05%
|
8.49%
|
4.58%
|
8.22%
|
10.33%
|
1.58%
|
6.19%
|
3.36%
|
6.78%
|
1.48%
|
-
|
1.71%
|
-
|
-
|
7.66%
|
EPS
2 |
94.20
|
-
|
90.01
|
14.04
|
161.1
|
49.43
|
-42.72
|
-
|
93.81
|
12.44
|
106.2
|
30.14
|
56.92
|
70.92
|
9.720
|
80.64
|
20.82
|
44.06
|
9.400
|
-
|
21.90
|
-
|
-
|
117.4
|
Dividend per Share
2 |
80.00
|
-
|
80.00
|
-
|
80.00
|
-
|
-
|
80.00
|
-
|
-
|
80.00
|
-
|
-
|
-
|
80.00
|
80.00
|
-
|
80.00
|
-
|
85.00
|
-
|
-
|
85.00
|
-
|
Announcement Date
|
10/30/19
|
5/13/20
|
11/5/20
|
11/1/21
|
11/1/21
|
2/3/22
|
5/13/22
|
5/13/22
|
8/5/22
|
11/7/22
|
11/7/22
|
2/6/23
|
5/15/23
|
8/2/23
|
11/7/23
|
11/7/23
|
2/6/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
155,079
|
165,860
|
159,114
|
214,740
|
141,245
|
172,337
|
183,790
|
205,450
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
85,546
|
75,157
|
54,705
|
88,742
|
20,951
|
71,120
|
43,701
|
55,578
|
ROE (net income / shareholders' equity)
|
10.4%
|
18.6%
|
6.1%
|
6.6%
|
7.2%
|
5.12%
|
6.26%
|
8.56%
|
ROA (Net income/ Total Assets)
|
8.44%
|
12%
|
4.88%
|
4.68%
|
3.6%
|
3.07%
|
3.65%
|
5.28%
|
Assets
1 |
751,298
|
1,014,381
|
862,462
|
1,026,549
|
1,540,117
|
1,337,653
|
1,366,667
|
1,383,496
|
Book Value Per Share
2 |
2,193
|
2,366
|
2,453
|
2,612
|
2,789
|
2,792
|
2,825
|
2,917
|
Cash Flow per Share
2 |
315.0
|
543.0
|
274.0
|
301.0
|
333.0
|
337.0
|
303.0
|
337.0
|
Capex
1 |
27,622
|
50,226
|
38,100
|
40,467
|
25,269
|
35,700
|
35,600
|
37,100
|
Capex / Sales
|
4.3%
|
7.22%
|
5.9%
|
5.35%
|
3.39%
|
4.85%
|
4.58%
|
4.3%
|
Announcement Date
|
5/13/19
|
5/13/20
|
5/12/21
|
5/13/22
|
5/15/23
|
-
|
-
|
-
|
Last Close Price
6,549
JPY Average target price
8,154
JPY Spread / Average Target +24.51% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.19% | 11.92B | | +33.25% | 699B | | +29.34% | 571B | | -3.55% | 364B | | +18.16% | 326B | | +4.36% | 286B | | +15.00% | 236B | | +5.10% | 198B | | -10.51% | 194B | | -3.69% | 149B |
Other Pharmaceuticals
|